Davita - Wautoma Dialysis in Wautoma, Wisconsin - Dialysis Center

Davita - Wautoma Dialysis is a medicare approved dialysis facility center in Wautoma, Wisconsin and it has 8 dialysis stations. It is located in Waushara county at 900 East Division St, Wautoma, WI, 54982. You can reach out to the office of Davita - Wautoma Dialysis at (920) 787-1031. This dialysis clinic is managed and/or owned by Davita. Davita - Wautoma Dialysis has the following ownership type - Profit. It was first certified by medicare in April, 2005. The medicare id for this facility is 522563 and it accepts patients under medicare ESRD program.

Name	Davita - Wautoma Dialysis
Location	900 East Division St, Wautoma, Wisconsin
No. of Dialysis Stations	8
Medicare ID	522563
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Wautoma Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

Dialysis patients with Hemoglobin data	15
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	27

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	32
  Adult patient months included in Kt/V greater than or equal to 1.2	269
  Percentage of adult patients getting regular hemodialysis at the center	92
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Wautoma Dialysis with elevated calcium levels.

Patients with hypercalcemia	32
Hypercalcemia patient months	269
Hypercalcemia patients with serumcalcium greater than 10.2 mg	4
Patients with Serumphosphor	31
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	29
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	35
Patients with Serumphosphor from 5.6 to 7 mg/dL	20
Patients with Serumphosphor greater than 7 mg/dL	9

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	31
Patient months included in arterial venous fistula and catheter summaries	183
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	62
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	11

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	23
Hospitalization Rate in facility	96.8 (As Expected)
Hospitalization Rate: Upper Confidence Limit	302.5
Hospitalization Rate: Lower Confidence Limit	33.9